Tender detail
Conclusion of non-exclusive rebate agreements for etanercept and epoetin alfa/zeta
Summary
GWQ ServicePlus AG is procuring non-exclusive rebate agreements for the active substances etanercept (ATC L04AB01) and epoetin alfa/zeta (ATC B03XA01), on behalf of the health insurers in the ARGE-OH-BioTech group. The agreements are intended to start on 1 January 2027.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.